Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3Neoplasms 2Colonic Neoplasms 2Adenomatous Polyposis Coli 2Adenoma 2Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyps 1Overweight 1Obesity 1Non-alcoholic Fatty Liver Disease 1Neoplastic Syndromes, Hereditary 1Neoplasms, Germ Cell and Embryonal 1Medulloblastoma 1Intestinal Neoplasms 1Intestinal Diseases 1Hepatoblastoma 1Hepatitis 1Genetic Diseases, Inborn 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Esophageal Neoplasms 1Duodenal Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Chemical and Drug Induced Liver Injury 1

Interventions

Cisplatin 160Fluorouracil 134Paclitaxel 125Radiotherapy 117Oxaliplatin 87Carboplatin 71Docetaxel 70Irinotecan 59pembrolizumab 57Capecitabine 57Leucovorin 56Radiation 47Surgical Procedures, Operative 33Drug Therapy 33Esophagectomy 31Cetuximab 25Neoadjuvant Therapy 24Nivolumab 23Bevacizumab 21Trastuzumab 20camrelizumab 19S 1 (combination) 19Chemoradiotherapy 17Albumin-Bound Paclitaxel 16Magnetic Resonance Spectroscopy 15Epirubicin 15tislelizumab 14Taxes 13Radiotherapy, Intensity-Modulated 13Cyclophosphamide 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Esophageal Neoplasms × Ursodeoxycholic Acid × Clear all
NCT01097304 2017-12-19

Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia

National Cancer Institute (NCI)

Phase 2 Completed
36 enrolled 10 charts
Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡